This is not the most recent version of the article. View current version (15 FEB 2012)

Intervention Review

Bisphosphonates for breast cancer

  1. Nick Pavlakis1,*,
  2. Robert L Schmidt2,
  3. Martin R Stockler3

Editorial Group: Cochrane Breast Cancer Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 9 JAN 2007

DOI: 10.1002/14651858.CD003474.pub2

Database Title

Additional Information

How to Cite

Pavlakis N, Schmidt RL, Stockler MR. Bisphosphonates for breast cancer. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003474. DOI: 10.1002/14651858.CD003474.pub2.

Author Information

  1. 1

    Royal North Shore Hospital, Department of Medical Oncology, St Leonards, NSW, Australia

  2. 2

    Sydney University, Faculty of Medicine, Sydney, NSW, Australia

  3. 3

    University of Sydney, NHMRC Clinical Trials Centre and Sydney Cancer Centre, Camperdown, NSW, Australia

*Nick Pavlakis, Department of Medical Oncology, Royal North Shore Hospital, Pacific Highway, St Leonards, NSW, 2065, Australia. pavlakis@med.usyd.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (15 Feb 2012)

View Full Article (HTML) Summary (57K)Standard (435K)Full (501K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (57K)Standard (435K)Full (501K)